When specifically analyzing FL and DLBCL/LBCL, lymphomas for which these mutations were previously described, EZH2 mutations were seen in 9 of 60 FL tested (15%) and in 4 of the 25 DLBCL/LBCL samples tested (16%). This evidence concerns the gene EZH2 and lymphoma.